Abstract
O-Acyl isodipeptides are prepared by coupling Boc-Ser/Thr-OBzl with Fmoc-Xaa-OH employing COMU, well known third generation peptide coupling agent. The reaction proceeds with high yield and the chemical homogeneity of the synthesized molecules were established via chiral HPLC analyses. The O-acyl isodipeptide units play crucial role in the success of ‘click peptide’ protocol employed for assembling ‘difficult sequence’ peptides.
Keywords: O-acyl isodipeptide, click peptide, difficult sequence, COMU, esterification
Protein & Peptide Letters
Title:Epimerization Free Synthesis of O-Acyl Isodipeptides Employing COMU
Volume: 19 Issue: 4
Author(s): M. Samarasimhareddy, Hosahalli P. Hemantha, Kuppanna Ananda and Vommina V. Sureshbabu
Affiliation:
Keywords: O-acyl isodipeptide, click peptide, difficult sequence, COMU, esterification
Abstract: O-Acyl isodipeptides are prepared by coupling Boc-Ser/Thr-OBzl with Fmoc-Xaa-OH employing COMU, well known third generation peptide coupling agent. The reaction proceeds with high yield and the chemical homogeneity of the synthesized molecules were established via chiral HPLC analyses. The O-acyl isodipeptide units play crucial role in the success of ‘click peptide’ protocol employed for assembling ‘difficult sequence’ peptides.
Export Options
About this article
Cite this article as:
Samarasimhareddy M., P. Hemantha Hosahalli, Ananda Kuppanna and V. Sureshbabu Vommina, Epimerization Free Synthesis of O-Acyl Isodipeptides Employing COMU, Protein & Peptide Letters 2012; 19 (4) . https://dx.doi.org/10.2174/092986612799789413
DOI https://dx.doi.org/10.2174/092986612799789413 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Partial QSAR Analysis of Some Selected Natural Inhibitors of FAAH Suggests a Working Hypothesis for the Development of Endocannabinoid- Based Drugs
Current Drug Targets - CNS & Neurological Disorders A Review of Eugenol-based Nanomedicine: Recent Advancements
Current Bioactive Compounds Neuroprotective Effects of a Glutathione Depletor in Rat Post-Ischemic Reperfusion Brain Damage
CNS & Neurological Disorders - Drug Targets The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer’s Dementia Using the NACC Database
Current Alzheimer Research Targeting Tau Hyperphosphorylation <I>via</I> Kinase Inhibition: Strategy to Address Alzheimer's Disease
Current Topics in Medicinal Chemistry Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets A Quantitative Structure-Activity Relationship Study on Some Imidazoles and 2-Aminopyridines Acting as Nitric Oxide Synthase (NOS) Inhibitors
Letters in Drug Design & Discovery Glaucoma Disease: A Survey
Current Medical Imaging Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR Study
Current Pharmaceutical Design Recommendations for the Treatment of Hypertension in Elderly People
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Oral Anticoagulants in the Treatment of Acute Coronary Syndromes: Is there any Room for New Anticoagulants?
Current Clinical Pharmacology Polyoxometalates in Biomedicine: Update and Overview
Current Medicinal Chemistry New Strategies for Clinical Trials in Autism Spectrum Disorder
Reviews on Recent Clinical Trials Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) Bioactives in Disease Prevention and Health Promotion: Exploiting Combinatorial Effects
Current Bioactive Compounds Platelet Glycoprotein IIb / IIIa Inhibition and its Clinical Use
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Amyloid Beta: The Alternate Hypothesis
Current Alzheimer Research Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities
CNS & Neurological Disorders - Drug Targets